NDC 36987-2447
Acacia
Acacia
Acacia is a Intradermal; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Nelco Laboratories, Inc.. The primary component is Acacia Baileyana Pollen.
| Product ID | 36987-2447_90c4b6c4-a7f2-4ba8-927c-8440e0df96f5 |
| NDC | 36987-2447 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Acacia |
| Generic Name | Acacia |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRADERMAL; SUBCUTANEOUS |
| Marketing Start Date | 1972-08-29 |
| Marketing Category | BLA / BLA |
| Application Number | BLA102192 |
| Labeler Name | Nelco Laboratories, Inc. |
| Substance Name | ACACIA BAILEYANA POLLEN |
| Active Ingredient Strength | 20000 [PNU]/mL |
| Pharm Classes | Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [CS],Allergens [CS] |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
Packaging
NDC 36987-2447-3
30 mL in 1 VIAL, MULTI-DOSE (36987-2447-3)
| Marketing Start Date | 1972-08-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 36987-2447-4 [36987244704]
Acacia INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2447-2 [36987244702]
Acacia INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2447-3 [36987244703]
Acacia INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
NDC 36987-2447-1 [36987244701]
Acacia INJECTION, SOLUTION
| Marketing Category | BLA |
| Application Number | BLA102192 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1972-08-29 |
| Inactivation Date | 2019-10-21 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| ACACIA BAILEYANA POLLEN | 20000 [PNU]/mL |
OpenFDA Data
Pharmacological Class
- Non-Standardized Pollen Allergenic Extract [EPC]
- Increased Histamine Release [PE]
- Cell-mediated Immunity [PE]
- Increased IgG Production [PE]
- Pollen [CS]
- Allergens [CS]
NDC Crossover Matching brand name "Acacia" or generic name "Acacia"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0268-1000 | ACACIA | Acacia |
| 0268-1001 | ACACIA | Acacia |
| 0268-6600 | ACACIA | Acacia |
| 0268-6676 | ACACIA | Acacia |
| 36987-2445 | Acacia | Acacia |
| 36987-2446 | Acacia | Acacia |
| 36987-2447 | Acacia | Acacia |
| 36987-2448 | Acacia | Acacia |
| 36987-2449 | Acacia | Acacia |
| 36987-2450 | Acacia | Acacia |
| 36987-2451 | Acacia | Acacia |
| 36987-2452 | Acacia | Acacia |
| 54575-901 | ACACIA POLLEN | acacia |
Trademark Results [Acacia]
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.